# US 2024/0392335 A1 · Chondroitin-producing recombinant cell

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0392335 A1
- Document ID: US20240392335A1
- Status: Published application
- Kind: A1
- Application number: 18/553,310
- Filed: 2022-03-31
- Published: 2024-11-28
- Earliest claimed: 2021-04-01
- Assignees: Givaudan SA
- Applicants: Givaudan SA
- Inventors: Dominique LOUIS; Karine JAILLARDON; Muriel MERKAMM; Dominique THOMAS
- Web page: https://patentgrep.com/patent/US20240392335A1

## CPC

- C12P 19/26: Preparation of nitrogen-containing carbohydrates
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12N 9/1096: {transferring nitrogenous groups (2.6)}
- C12N 9/1241: {Nucleotidyltransferases (2.7.7)}
- C12N 9/88: Lyases (4.)
- C12N 9/90: Isomerases (5.)
- C12N 15/81: for yeasts
- C12Y 101/01022: UDP-glucose 6-dehydrogenase (1.1.1.22)
- C12Y 203/01004: Glucosamine-phosphate N-acetyltransferase (2.3.1.4)
- C12Y 206/01016: Glutamine-fructose-6-phosphate transaminase (isomerizing) (2.6.1.16), i.e. glucosamine-6-phosphate-synthase
- C12Y 207/07009: UTP-glucose-1-phosphate uridylyltransferase (2.7.7.9), i.e. UDP-glucose-pyrophosphorylase
- C12Y 207/07023: UDP-N-acetylglucosamine diphosphorylase (2.7.7.23)
- C12Y 402/02004: Chondroitin ABC lyase (4.2.2.4), i.e. chondroitinase (C12Y402/0202, C12Y402/02021 take precedence)
- C12Y 501/03002: UDP-glucose 4-epimerase (5.1.3.2), i.e. UDP-galactose 4-epimerase
- C12Y 504/02002: Phosphoglucomutase (5.4.2.2)
- C12Y 504/02003: Phosphoacetylglucosamine mutase (5.4.2.3)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present invention relates to the field of bio-production of chondroitin. There is a need in the art for chondroitin production methods allowing its highly efficient synthesis and secretion. The solution proposed in the present invention is the use of a recombinant cell, in particular a recombinant yeast, comprising many modifications as described in the present text. The present invention further proposes methods allowing the bio-production of chondroitin using the recombinant cell, in particular a recombinant yeast, of the invention.

## Claims

### Claim 1

A recombinant host cell (i) or a recombinant yeast cell ii) producing chondroitin wherein the recombinant host cell (i) or the recombinant yeast cell ii) comprises:
(a) one or more recombinant nucleic acids encoding a polypeptide having a chondroitin synthase (HCOS) activity;
(b) one or more recombinant nucleic acids encoding a polypeptide having UDP-Glucose dehydrogenase (UDP-GlcDH or HASB) activity; and
(c) one or more recombinant nucleic acids encoding a polypeptide having a UDP-glucose-4-epimerase (kfoA or GNE1) activity,
wherein the recombinant host cell (i) further comprises (d) one or more recombinant nucleic acids encoding a polypeptide having a chondroitinase activity wherein the polypeptide having chondroitinase activity comprises a secretion signal so that chondroitin is produced by the recombinant host cell (i), and
wherein the recombinant yeast cell (ii) optionally further comprises (d) one or more recombinant nucleic acids encoding a polypeptide having a chondroitinase activity wherein the polypeptide having chondroitinase activity comprises a secretion signal.

### Claim 2 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the polypeptide having chondroitinase activity comprises a secretion signal, and an anchoring signal.

### Claim 3 (depends on 1)

The recombinant host cell (i) according to claim 1 wherein the chondroitin is of a desired molecular weight.

### Claim 4 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the recombinant nucleic acid encoding a polypeptide having a chondroitinase activity is obtained or derived from at least one of Cupiennius salei, Tityus serrulatus, Bos taurus, Vespa magmfica, Macaca mulatta or Apis mellifera.

### Claim 5 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the molecular weight of the chondroitin is less than 50 kDa, or is in a range of 20 kDa to 50 kDa.

### Claim 6 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the molecular weight of the chondroitin is greater than 50 kDa, or is in a range of 50 kDa to 250 kDa or is greater than 100 kDa or is in a range of 100 kDa to 1500 kDa.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the nucleic acid encoding a polypeptide having a UDP-Glucose dehydrogenase (UDP-GlcDH or HASB) activity is obtained or derived from at least one of Arabidopsis thaliana, Chlorella virus PBCV1 or Streptococcus zooepidemicus.

### Claim 9 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the nucleic acid encoding a polypeptide having a chondroitin synthase (HCOS) activity is
(i) a nucleic acid encoding a chondroitin synthase; or
(ii) a nucleic acid encoding a chimeric polypeptide having a chondroitin synthase activity.

### Claim 10 (depends on 9)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 9, wherein the nucleic acid is obtained or derived from at least one of Pasteurella multocida, Chlorella virus PBCV1, Mycobacterium tuberculosis, Homo Sapiens, Escherichia coli, Saccharomyces cerevisiae or Penicillium oxalicum.

### Claim 11 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the nucleic acid encoding a polypeptide having a UDP-glucose-4-epimerase (kfoA or GNE1) activity is obtained or derived from a bacteria.

### Claim 12 (depends on 1)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1, wherein the recombinant cell further comprises at least one recombinant nucleic acid encoding one or more of:
(i) a polypeptide having glutamine-fructose-6-phosphate amidotransferase (GFA1) activity; and/or
(ii) a polypeptide having UDP-N-acetylglucosamine pyrophosphorylase (QRI1) activity; and/or
(iii) a polypeptide having phosphoglucomutase-1 (PGM1) activity; and/or
(iv) a polypeptide having UTP-glucose-1-phosphate uridylyltransferase (UGP1) activity;
(v) a polypeptide having glucosamine-6-phosphate N-acetyltransferase (GNA1) activity; and/or
(vi) a polypeptide having phosphoacetylglucosamine mutase (PCM1) activity.

### Claim 13

(canceled)

### Claim 14 (depends on 12)

The recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 12, wherein:
the nucleic acid encoding the polypeptide having glutamine-fructose-6-phosphate amidotransferase (GFA1) activity;
the nucleic acid encoding the polypeptide having UDP-N-acetylglucosamine pyrophosphorylase (QRI1) activity;
the nucleic acid encoding the polypeptide having Phosphoglucomutase-1 (PGM1) activity;
the nucleic acid encoding the polypeptide having UTP-glucose-1-phosphate uridylyltransferase (UGP1) activity;
the nucleic acid encoding the polypeptide having Glucosamine-6-phosphate N-acetyltransferase (GNA1) activity; and/or
the nucleic acid encoding the polypeptide having phosphoacetylglucosamine mutase (PCM1);
are obtained or derived from Saccharomyces cerevisiae.

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The recombinant yeast cell ii) according to claim 1, wherein the yeast belongs to a genus selected from the group consisting of Saccharomyces, Candida, Kluyveromyces, Ogataea, Yarrowia, Debaryomyces and Ashbya.

### Claim 17 (depends on 16)

The recombinant yeast cell ii) according to claim 16, wherein the yeast is selected from the group consisting of Saccharomyces cerevisiae, Saccharomyces boulardii, Saccharomyces bayanus, Saccharomyces paradoxus, Saccharomyces mikatae, Saccharomyces castelli, Candida albicans, Candida glabrata, Candida tropicalis, Kluyveromyces lactis, Kluyveromyces marxianus, Kluyveromyces polysporus, Kluyveromyces thermotolerans Ogataea polymorpha, Yarrowia lypolytica, Debaryomyces hansenii, and Ashbya gossypii.

### Claim 18 (depends on 1)

A method of producing chondroitin of a desired molecular weight comprising:
(a) cultivating the recombinant host cell (i) or the recombinant yeast cell (ii) as defined in claim 1 in a cultivation medium for a time sufficient to produce chondroitin of the desired molecular weight; and
(b) optionally isolating or recovering the chondroitin from the recombinant host cell (i) or the recombinant yeast cell (ii) and/or from the cultivation medium.

### Claim 19 (depends on 18)

The method of claim 18, wherein the chondroitin has a molecular weight of from 20 kDa to 50 kDa, or from 50 kDa to 150 kDa or from 150 kDa to 1500 kDa.

### Claim 20

(canceled)

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 18)

The method according to claim 18, wherein the time sufficient to produce chondroitin of a desired molecular weight is a period of from 35 hours to 50 hours, preferably or from 40 hours to 50 hours, or is 48 hours.

### Claim 24 (depends on 18)

The method according to claim 18, wherein the molecular weight of the chondroitin is controlled by regulating the pH of the cultivation medium during step (a).

### Claim 25 (depends on 18)

The method according to claim 18, wherein the method is carried out on an industrial scale, where the cultivation medium is at least 100 L, or is in the range of 1,000 L to 3,000 L, or is about 10,000 L or is 100,000 L, or is about 250,000 L.

### Claim 26 (depends on 1)

Chondroitin obtainable from the recombinant host cell (i) or the recombinant yeast cell (ii) according to claim 1.

### Claim 27 (depends on 26)

A cultivation medium comprising the chondroitin according to claim 26.

### Claim 28 (depends on 26)

A composition comprising the chondroitin according to claim 26.

### Claim 29 (depends on 5)

An industrial product or a consumer product or a consumable comprising (i) the chondroitin of claim 5, (ii) a cultivation medium comprising the chondroitin or (iii) a composition comprising the chondroitin.

### Claim 30 (depends on 29)

The industrial product or the consumer product or the consumable of claim 29, wherein the industrial product or the consumer product or the consumable is a cosmetic product, a flavour product, a fragrance product, a food product, a food, a beverage, a texturant, a pharmaceutical composition, a dietary supplement, a nutraceutical, a cleaning product, a dental and/or an oral hygiene composition.

### Claim 31

(canceled)

### Claim 32 (depends on 1)

A method for producing chondroitin, comprising the steps of:
(a) culturing the recombinant yeast cell ii) according to claim 1 in a cultivation medium; and
(b) recovering the chondroitin from said cultivation medium,
wherein the chondroitin recovered in step (b) has a molecular weight controlled through the selection of:
the nature and origin of the recombinant nucleic acid encoding a polypeptide having a chondroitinase activity of the recombinant yeast ii),
the nature and origin of the promoter controlling expression of a recombinant nucleic acid encoding a polypeptide having a chondroitinase activity of the recombinant yeast,
the presence of an anchoring and/or of a secretion signal associated with the polypeptide having a chondroitinase activity of the recombinant yeast,
the pH of the cultivation medium during the step of culturing the recombinant yeast, and/or
the duration of the step of culturing of the recombinant yeast.
